Staurosporine and Extracellular Matrix Proteins Mediate the Conversion of Small Cell Lung Carcinoma Cells into a Neuron-Like Phenotype-Reference-Cited by-同舟云学术

Staurosporine and Extracellular Matrix Proteins Mediate the Conversion of Small Cell Lung Carcinoma Cells into a Neuron-Like Phenotype

Published:2014-02-28 Issue:2 Volume:9 Page:e86910
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Murmann Tamara,Carrillo-García Carmen,Veit Nadine,Courts Cornelius,Glassmann Alexander,Janzen Viktor,Madea Burkhard,Reinartz Markus,Harzen Anne,Nowak Michael,Perner Sven,Winter Jochen,Probstmeier Rainer

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Advances in neuroendocrine lung tumors;WD Travis;Ann Oncol,2010

2. Trends in incidence of small cell lung cancer and all lung cancer;SP Riaz;Lung Cancer,2012

3. Characterization of the cell of origin for small cell lung cancer;KS Park;Cell Cycle,2011

4. Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung;KD Sutherland;Cancer Cell,2011

5. Transcriptional gene expression profiling of small cell lung cancer cells;N Pedersen;Cancer Res,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options;Cancers;2023-02-23

2. The Presence of Yin-Yang Effects in the Migration Pattern of Staurosporine-Treated Single versus Collective Breast Carcinoma Cells;International Journal of Molecular Sciences;2021-11-04

3. Bioinformatics Analysis of Dysregulated MicroRNA-Messenger RNA Networks in Small Cell Lung Cancer;Journal of Biomaterials and Tissue Engineering;2021-04-01

4. Staurosporine Induces the Generation of Polyploid Giant Cancer Cells in Non-Small-Cell Lung Carcinoma A549 Cells;Analytical Cellular Pathology;2018-10-10

5. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation;Cellular Oncology;2018-06-11